Reports on Hypertension Findings from Hudson Institute for Medical Research Provide New Insights [A Randomized Trial Assessing Efficacy and Safety of Mineralocorticoid Receptor Antagonist Therapy Compared To Standard Antihypertensive Therapy In...].

The article offers information on a study comparing the efficacy of mineralocorticoid receptor antagonists (MRAs) versus standard antihypertensive therapies in managing low-renin hypertension. Topics discussed include the rationale for using MRAs in low-renin hypertension; the study design and participant criteria; and the potential impact of the trial results on future hypertension guidelines.